Skip to main content

Table 1 Clinical summary, management, and outcome of all reported cases of isilated Nocardia scleritis

From: Nocardia scleritis—clinical presentation and management: a report of three cases and review of literature

Sl no. Author Eye Age Sex Predisposing factor Duration of symptoms Presenting VA Final VA Treatment—medical Treatment—surgical Outcome
1 Kattan [3] OD 63 F Scleral buckle, cataract surgery 2 weeks 1/200 NA Topical and TMP-SMX (iv) Eviseration Eviseration
2 King [5] OD 77 M Scleral buckle, cataract surgery 14 weeks 20/60 20/40 Topical 10% sulphacetamide, TMP-SMX (iv) Buckle removal Resolved
3 Brooks [4] OS 90 F Cataract surgery 5 weeks 20/80 NA Topical amikacin, topical and oral TMP-SMX Surgical debridement, scleral patch graft Resolved
4 Basti [2] OD 58 M Injury with vegetable material, steroids 1 month 20/200 20/40 Cefazolin (systemic and topical) Nil Resolved
5 Knox [8] OS 83 M Explantation of exposed buckle, steroids NA 20/100 20/60 Topical amikacin 2.5%, TMP-SMX 160/800 Nil Resolved
6 Choudhry [10] OS 54 M Steroids 7 Weeks 20/30 NA Cefazolin (systemic and topical), TMP-SMX 160/800, 10% sulphacetamide Surgical debridement Worsened and lost to follow up
7 Das [9] OS 40 F Mud splash, steroids 7 weeks 20/20 20/20 Topical TMP-SMX 160/800, amikacin 2.5%, amoxycillin/clavulanate (800/125 mg) Nil Resolved
8 Seth [6] OD 80 F Subtenon steroid 3 months 20/400 CF 1 m Topical trimetho prim/polymixin B, minocycline 100 mg/day Scleral exploration and biopsy and bovine pericardium patch graft Resolved
9 Jain [11] OD-2 OS-1 60.66 ± 7.36 M-3 Scleral buckle—n = 2 1–2 months 20/125–20/400 20/80–20/400 Topical amikacin—all cases, TMP-SMX 160/800—n = 2 Debridement n = 1 Resolved—all
10 DeCroos [12] OD-8 OS-3 56.8 ± 13 M-11 Injury with organic material—n = 5 30.4 ± 16.8 days Mean BCVA—20/502 Mean BCVA—20/399 Topical amikacin/ciprofloxacin/cefazolin—n = 11 Surgical debridement—n = 8; conjunctival excision—n = 2; tissue adhesive—n = 1 Resolved
Scleral buckle—n = 1 Systemic amikacin—n = 3
PPV—n = 1
11 Maruo [13] OS 78 M Cataract surgery 2 months 20/30 20/16 Topical tobramycin, moxifloxacin, oral TMP-SMX Debridement Resolved
  1. OD right eye, OS left eye, NA not available, VA visual acuity, TMP-SMX trimethoprim 160–800, PPV pars plana vitrectomy